PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Preventive placement of ICDs for less severe heart failure may improve survival

2014-06-03
(Press-News.org) An examination of the benefit of preventive placement of implantable cardioverter-defibrillators (ICDs) in patients with a less severe level of heart failure, a group not well represented in clinical trials, finds significantly better survival at three years than that of similar patients with no ICD, according to a study in the June 4 issue of JAMA.

Although clinical trials have established the ICD as the best currently available therapy to prevent sudden cardiac death in patients with heart failure, some uncertainties remain regarding preventive use of ICDs in patients seen in clinical practice. Of patients enrolled in randomized clinical trials of prophylactic (preventive) ICDs, the median left ventricular ejection fraction (LVEF; the percentage of blood that is pumped out of a filled ventricle as a result of a heartbeat) is well below 30 percent. Because a large number of prophylactic ICDs in the United States are implanted in patients with an LVEF between 30 percent and 35 percent, understanding outcomes associated with the ICDs in such patients is important. The Centers for Medicare & Medicaid Services have designated these patients as an important subgroup for whom more data on ICD effectiveness are needed, according to background information in the article.

Sana M. Al-Khatib, M.D., MH.S., of the Duke University Medical Center, Durham, N.C., and colleagues compared survival in Medicare beneficiaries in the National Cardiovascular Data Registry ICD registry with an LVEF between 30 percent and 35 percent who received an ICD during a heart failure hospitalization with similar patients in the Get With The Guidelines-Heart Failure database with no ICD. The analysis was repeated in patients with an LVEF less than 30 percent.

There were no significant differences in the baseline characteristics of the matched groups (n = 408 for both groups). At 1 year, 24.5 percent of ICD patients died vs 24.9 percent of non-ICD patients. At 3 years, 51.4 percent of the ICD patients died, compared with 55.0 percent of the non-ICD patients, a significantly lower risk of death among patients with an LVEF between 30 percent and 35 percent who received an ICD. Presence of an ICD also was associated with better survival in patients with an LVEF less than 30 percent (3-year mortality rates: 45.0 percent vs 57.6 percent).

The authors write that although the difference in absolute risk by 3 years was not large (3.6 percent), it was significant and close in magnitude to what was observed in other clinical trials of prophylactic ICDs. "These results support guidelines' recommendations to implant a prophylactic ICD in eligible patients with an LVEF of 35 percent or less." INFORMATION: (doi:10.1001/jama.2014.5310; Available pre-embargo to the media at http://media.jamanetwork.com)

Editor's Note: This analysis was funded by a grant from the National Heart, Lung, and Blood Institute. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.



ELSE PRESS RELEASES FROM THIS DATE:

Study: New test predicts if breast cancer will spread

Study: New test predicts if breast cancer will spread
2014-06-03
June 3, 2014 – BRONX, NY – The study was led by researchers at the National Cancer Institute (NCI)─designated Albert Einstein Cancer Center of Albert Einstein College of Medicine of Yeshiva University and Montefiore Einstein Center for Cancer Care and was published online today in the Journal of the National Cancer Institute (JNCI). "Tests assessing metastatic risk can help doctors identify which patients should receive aggressive therapy and which patients should be spared," said Thomas Rohan, M.D., Ph.D., the lead and corresponding author of the study and professor ...

Deeper than ancestry.com, 'EvoCor' identifies gene relationships

Deeper than ancestry.com, EvoCor identifies gene relationships
2014-06-03
A frontier lies deep within our cells. Our bodies are as vast as oceans and space, composed of a dizzying number of different types of cells. Exploration reaches far, yet the genes that make each cell and tissue unique have remained largely obscure. That's changing with the help of a team led by Gregorio Valdez, an assistant professor at the Virginia Tech Carilion Research Institute. Valdez and his team designed a search engine – called EvoCor – that identifies genes that are functionally linked. The name, a portmanteau of "evolution" and "correlation," points to ...

New definition of kidney disease for clinical trials could lead to new treatments

2014-06-03
A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health suggests that new therapies for kidney disease could be developed more quickly by revising the definition of kidney disease progression used during clinical trials. If adopted, the new definition could shorten the length of some clinical trials and also potentially encourage more clinical trials in kidney disease. The findings will be published in the June 3, 2014 online edition of the Journal of the American Medical Association. Chronic kidney disease (CKD) is a worldwide public health ...

2-D transistors promise a faster electronics future

2-D transistors promise a faster electronics future
2014-06-03
Faster electronic device architectures are in the offing with the unveiling of the world's first fully two-dimensional field-effect transistor (FET) by researchers with the Lawrence Berkeley National Laboratory (Berkeley Lab). Unlike conventional FETs made from silicon, these 2D FETs suffer no performance drop-off under high voltages and provide high electron mobility, even when scaled to a monolayer in thickness. Ali Javey, a faculty scientist in Berkeley Lab's Materials Sciences Division and a UC Berkeley professor of electrical engineering and computer science, led ...

Investigating unusual three-ribbon solar flares with extreme high resolution

2014-06-03
The 1.6 meter telescope at Big Bear Solar Observatory (BBSO) in California has given researchers unparalleled capability for investigating phenomena such as solar flares. Operated by New Jersey Institute of Technology (NJIT), the BBSO instrument is the most powerful ground-based telescope dedicated to studying the star closest to Earth. On June 2, Distinguished Professor of Physics Haimin Wang joined NJIT colleagues at the 224th meeting of the American Astronomical Society (AAS), held in Boston, Massachusetts, to present intriguing data about solar flares — specifically, ...

Solving sunspot mysteries

2014-06-03
Multi-wavelength observations of sunspots with the 1.6-meter telescope at Big Bear Solar Observatory (BBSO) in California and aboard NASA's IRIS spacecraft have produced new and intriguing images of high-speed plasma flows and eruptions extending from the Sun's surface to the outermost layer of the solar atmosphere, the corona. Operated by New Jersey Institute of Technology (NJIT), BBSO houses the largest ground-based telescope dedicated to solar research. On June 2, NJIT researchers reported on the acquisition of these images at the 224th meeting of the American Astronomical ...

Complex neural circuitry keeps you from biting your tongue

Complex neural circuitry keeps you from biting your tongue
2014-06-03
DURHAM, N.C. -- Eating, like breathing and sleeping, seems to be a rather basic biological task. Yet chewing requires a complex interplay between the tongue and jaw, with the tongue positioning food between the teeth and then moving out of the way every time the jaw clamps down to grind it up. If the act weren't coordinated precisely, the unlucky chewer would end up biting more tongue than burrito. Duke University researchers have used a sophisticated tracing technique in mice to map the underlying brain circuitry that keeps mealtime relatively painless. The study, ...

Climate engineering can't erase climate change

Climate engineering cant erase climate change
2014-06-03
Tinkering with climate change through climate engineering isn't going to help us get around what we have to do says a new report authored by researchers at six universities, including Simon Fraser University. After evaluating a range of possible climate-altering approaches to dissipating greenhouse gases and reducing warming, the interdisciplinary team concluded there's no way around it. We have to reduce the amount of carbon being released into the atmosphere. "Some climate engineering strategies look very cheap on paper. But when you consider other criteria, like ...

Fatty liver disease prevented in mice

Fatty liver disease prevented in mice
2014-06-03
Studying mice, researchers have found a way to prevent nonalcoholic fatty liver disease, the most common cause of chronic liver disease worldwide. Blocking a path that delivers dietary fructose to the liver prevented mice from developing the condition, according to investigators at Washington University School of Medicine in St. Louis. The study appears in a recent issue of the Journal of Biological Chemistry. In people, nonalcoholic fatty liver disease often accompanies obesity, elevated blood sugar, high blood pressure and other markers of metabolic syndrome. Some ...

Researchers shut down a SARS cloaking system; findings could lead to SARS, MERS vaccines

Researchers shut down a SARS cloaking system; findings could lead to SARS, MERS vaccines
2014-06-03
WEST LAFAYETTE, Ind. —A Purdue University-led research team has figured out how to disable a part of the SARS virus responsible for hiding it from the immune system; a critical step in developing a vaccine against the deadly disease. The findings also have potential applications in the creation of vaccines against other coronaviruses, including MERS, said Andrew Mesecar, who led the research. "This is a first step toward creating a weakened and safe virus for use in an attenuated live vaccine," said Mesecar, Purdue's Walther Professor of Cancer Structural Biology and ...

LAST 30 PRESS RELEASES:

University of Cincinnati experts present research at annual hematology event

ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial

ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer

ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors

Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient

Continuous and fixed-duration treatments result in similar outcomes for CLL

Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia

Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease

Roughly one-third of families with children being treated for leukemia struggle to pay living expenses

Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy

IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection

Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients

Emergency departments fall short on delivering timely treatment for sickle cell pain

Study shows no clear evidence of harm from hydroxyurea use during pregnancy

Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease

Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia

Early results suggest exa-cel gene therapy works well in children

NTIDE: Disability employment holds steady after data hiatus

Social lives of viruses affect antiviral resistance

Dose of psilocybin, dash of rabies point to treatment for depression

Helping health care providers navigate social, political, and legal barriers to patient care

Barrow Neurological Institute, University of Calgary study urges “major change” to migraine treatment in Emergency Departments

Using smartphones to improve disaster search and rescue

Robust new photocatalyst paves the way for cleaner hydrogen peroxide production and greener chemical manufacturing

Ultrafast material captures toxic PFAS at record speed and capacity

Plant phenolic acids supercharge old antibiotics against multidrug resistant E. coli

UNC-Chapel Hill study shows AI can dramatically speed up digitizing natural history collections

OYE Therapeutics closes $5M convertible note round, advancing toward clinical development

Membrane ‘neighborhood’ helps transporter protein regulate cell signaling

Naval aviator turned NPS doctoral student earns national recognition for applied quantum research

[Press-News.org] Preventive placement of ICDs for less severe heart failure may improve survival